GLP-1在不同組織中具有多種作用和廣泛的治療潛力。

GLP-1 shows numerous actions in different tissues, and a broad therapeutic potential.

GLP-1的主要作用是刺激胰島素分泌并抑制胰高血糖素分泌，從而有助于控制餐后血糖波動(dòng)。

The main actions of GLP-1 are to stimulate insulin secretion and to inhibit glucagon secretion,thereby contributing to limit postprandial glucose excursions.

GLP-1 可以增強(qiáng)飽腹感而導(dǎo)致體重減輕，此外，GLP-1還抑制胃腸道運(yùn)動(dòng)和分泌，可以充當(dāng)腸胃素和“回腸制動(dòng)”機(jī)制的一部分。

GLP-1 also causes weight loss by increasing satiety. In addition, GLP-1 also inhibits gastrointestinal motility and secretion,and thus acts as an enterogastrone and part of the "ileal brake" mechanism.

“GLP-1”新藥研發(fā)服務(wù)平臺(tái)

胰高血糖素樣肽-1(GLP-1s) 介紹

GLP-1讓打針吃藥也能減肥成為現(xiàn)實(shí)

針對(duì)NASH非酒精性脂肪肝有哪些不同的新藥類型